semaglutide patent expiration us Indian pharma companies launch low-cost generic Indian Pharma Billionaires Pile Into

(2024) Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor

Semaglutide (Wegovy and Ozempic) is FDA-approved for managing blood sugar levels in patients with type 2 diabetes mellitus and promoting weight loss in obese and overweight patients with at least one weight-related health condition, when used along with lifestyle changes such as a low-calorie diet and increased physical activity

Retatrutide (triple agonist) If tirzepatide was a step forward, retatrutide is a leap

Smits and colleagues, Frontiers in Endocrinology , 2021.) Because the drug slows the stomach, retained food can raise aspiration risk during surgery or a scope, so many guidelines now advise pausing it before procedures, a decision your clinician makes

Heres how they work, who they might benefit and some of the different types available

Biomedicines 13, 445